ABPI response to NICE process review

NICE has launched a public consultation on proposals for changes to the processes it uses to develop its guidance on medicines, medical devices, diagnostics and digital health technologies.

In response, Dr Paul Catchpole, ​Director of Value and Access Policy at the ABPI, said:

“We should use the opportunity of the process review to deliver greater consistency, predictability, and rigour in how companies experience working with NICE in the future.

“This will include making sure there are efficient and timely engagement mechanisms throughout appraisals so that the right decisions are made for patients, at the right time.”